| abstract |
Diseases for reducing blood cholesterol, low density lipoprotein (LDL) levels and / or high cholesterol, hyperlipidemia, dyslipidemia, or high levels of low density lipoprotein (LDL) Provided herein is a method for the treatment of a method comprising the step of administering a DRP1 inhibitor to a subject in need thereof. In certain embodiments, a subject is selected for treatment as described herein if the subject is intolerant to conventional statin therapy. The use of DRP1 inhibitors in the treatment of cancer and inflammatory diseases is also envisaged herein. |